Literature DB >> 20673275

Standing lateral thoracotomy in horses: indications, complications, and outcomes.

Hugo Hilton1, Monica Aleman, John Madigan, Jorge Nieto.   

Abstract

OBJECTIVE: To describe the indications for, complications arising from, and outcome of horses that had standing lateral thoracotomy for pleural or pericardial disease. STUDY
DESIGN: Case series. ANIMALS: Horses (n=16).
METHODS: Medical records (January 1990-December 2008) of sedated standing horses that had lateral thoracotomy were reviewed. Clinical and surgical findings, perioperative and short-term complications were recorded. Long-term (>6 months) outcome was determined through telephone conversations with owners and veterinarians.
RESULTS: Mean (±SD) horse age was 6.6±5.3 years (range, 1-15 years). Thoracotomy was most commonly for treatment of recurrent or chronic pleural infection (94%). Anaerobic bacteria were frequently isolated from pleural effusion associated with pleuropneumonia (63%). Right lateral intercostal thoracotomy was performed in 13 horses (82%); intercostal muscle myectomy in 5 horses; and rib resection in 1. Perioperative complications were hemipneumothorax (2 horses) and short-term complications included cellulitis and abscessation of the thoracotomy site (6 horses). Fourteen (88%) horses survived to discharge and 46% of horses that survived returned to their previous level of athletic activity.
CONCLUSIONS: Lateral thoracotomy is well tolerated by standing sedated horses with minimal perioperative and short-term complications. CLINICAL RELEVANCE: Standing lateral thoracotomy should be considered for the treatment of complicated pleuropneumonia in horses. © Copyright 2010 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2010        PMID: 20673275     DOI: 10.1111/j.1532-950X.2010.00713.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  2 in total

1.  Factors Associated with Survival in 97 Horses with Septic Pleuropneumonia.

Authors:  M G Arroyo; N M Slovis; G E Moore; S D Taylor
Journal:  J Vet Intern Med       Date:  2017-03-08       Impact factor: 3.333

2.  The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012).

Authors:  J E Tomlinson; E Byrne; N Pusterla; K Gary Magdesian; H G Hilton; B McGorum; E Davis; A Schoster; L Arroyo; B Dunkel; H Carslake; R C Boston; A L Johnson
Journal:  J Vet Intern Med       Date:  2015-08-07       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.